Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
Adoport 0.5 mg Capsules, hard.
| Pharmaceutical Form |
|---|
|
Capsule, hard. Opaque white and ivory hard gelatin capsule containing white to off- white powder. (length: 14.5 mm). |
Each hard capsule contains 0.5 mg of tacrolimus (as tacrolimus monohydrate).
Excipient with known effect:
Each hard capsule contains 46.1 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tacrolimus |
Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor. |
| List of Excipients |
|---|
|
Capsule contents: Hypromellose (E464) Hard gelatine capsule: Gelatin |
PVC/PE/PVdC/Aluminium blisters with desiccant in Aluminium bag.
Packs of 7, 10, 14, 20, 28, 30, 50, 60, 90 and 100 hard capsules.
Not all pack sizes may be marketed.
Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
PL 04416/0939
31/05/2014
| Drug | Countries | |
|---|---|---|
| ADOPORT | Spain, France, Italy, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
